AAAAAA
Results:
1-9
|
Results: 9
Authors:
Argiris, A
Murren, JR
Citation: A. Argiris et Jr. Murren, Staging and clinical prognostic factors for small-cell lung cancer, CANCER J, 7(5), 2001, pp. 437-447
Authors:
Argiris, A
Murren, JR
Citation: A. Argiris et Jr. Murren, Advances in chemotherapy for small cell lung cancer: Single-agent activityof newer agents, CANCER J, 7(3), 2001, pp. 228-235
Authors:
Argiris, A
Heald, P
Kuzel, T
Foss, FM
DiStasio, S
Cooper, DL
Arbuck, S
Murren, JR
Citation: A. Argiris et al., Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma, INV NEW DR, 19(4), 2001, pp. 321-326
Authors:
Murren, JR
DiStasio, SA
Lorico, A
McKeon, A
Zuhowski, EG
Egorin, MJ
Sartorelli, AC
Rappa, G
Citation: Jr. Murren et al., Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies, CANCER J, 6(4), 2000, pp. 256-265
Authors:
Jillella, AP
Murren, JR
Hamid, KK
Longley, BJ
Edelson, RL
Cooper, DL
Citation: Ap. Jillella et al., P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphoma, CANCER INV, 18(7), 2000, pp. 609-613
Authors:
Murren, JR
Peccerillo, K
DiStasio, SA
Li, X
Leffert, JJ
Pizzorno, G
Burtness, BA
McKeon, A
Cheng, YC
Citation: Jr. Murren et al., Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer, CANC CHEMOT, 46(1), 2000, pp. 43-50
Authors:
Rappa, G
Murren, JR
Johnson, LM
Lorico, A
Sartorelli, AC
Citation: G. Rappa et al., Novobiocin-induced VP-16 accumulation and MRP expression in human leukemiaand ovarian carcinoma cells, ANTI-CAN DR, 15(2), 2000, pp. 127-134
Authors:
Adjei, AA
Argiris, A
Murren, JR
Citation: Aa. Adjei et al., Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer, SEMIN ONCOL, 26(5), 1999, pp. 32-40
Authors:
Fossella, FV
Green, MR
Eckardt, JR
Wozniak, AJ
Socinski, MA
Murren, JR
Citation: Fv. Fossella et al., Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer - Discussion I, SEMIN ONCOL, 26(5), 1999, pp. 41-42
Risultati:
1-9
|